ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$13.58
-0.44%
Mkt Cap $658.26M
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (14 analysts)
$22.00
Range $18.00 – $29.00
Implied Upside
+62.0%
Consensus $22.00 vs current $13.58
NASDAQ·Healthcare·Biotechnology
$13.58
-0.44%
Mkt Cap $658.26M
Buy
15
Hold
0
Sell
0
Price Target (14 analysts)
$22.00
Range $18.00 – $29.00
+62.0%
Consensus $22.00 vs current $13.58